XML 47 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

NET LOSS PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
NET LOSS PER SHARE | NOTE 13. NET LOSS PER SHARE The below table is a reconciliation of net loss to net loss attributable to common stockholders. SCHEDULE OF RECONCILIATION OF NET LOSS
|  | 2024 |  |  | 2023 |
|  | Year ended |
|  | December 31, |
|  | 2024 |  |  | 2023 |
Net loss |  | $ | (13,727,380 | ) |  | $ | (60,477,680 | )
Series A cumulative preferred stock dividend |  |  | (76,712 | ) |  |  | — |
Series B stock repurchase |  |  | 3,613,000 |  |  |  | — |
Stock repurchase |  |  | 3,613,000 |  |  |  | — |
Series C cumulative preferred stock dividend |  |  | (82,603 | ) |  |  | — |
Cumulative preferred stock dividend |  |  | (82,603 | ) |  |  | — |
Net loss attributable to common stockholders |  | $ | (10,273,695 | ) |  | $ | (60,477,680 | )
The Company excluded the following potential shares from the computation of diluted net loss per share because including them would have had an anti-dilutive effect: SCHEDULE OF ANTI-DILUTIVE NET LOSS PER SHARE
|  | 2024 |  |  | 2023 |
|  | December 31, |
|  | 2024 |  |  | 2023 |
Outstanding RSUs (a) |  |  | 8,623,225 |  |  |  | 10,900,128 |
Restricted Stock |  |  | 19,348,954 |  |  |  | — |
Warrants |  |  | 17,974,978 |  |  |  | — |
Convertible promissory notes (b) |  |  | — |  |  |  | 891,298 |
Earnout Shares |  |  | 24,500,000 |  |  |  | — |
Total |  |  | 70,447,157 |  |  |  | 11,791,426 |
(a) | As of December 31, 2024 there were an additional 1,373,221 RSUs that had vested but had not been legally settled into common stock and therefore were included in the basic net income per share. See Note 11 for additional information.
(b) | The numbers of shares were determined based on the conversion upon maturity provisions in the convertible promissory note agreements, dividing the conversion amount (principal plus accrued interest) by three times the estimated fair value of the Company’s common stock derived from the Company’s most recently completed convertible promissory notes valuation as of the balance sheet date.
The above table excludes any potentially anti-dilutive shares as a result of the $14 million Purchase Option and the Additional Amount Purchase Option (see Note 8). These are excluded as the number of shares issuable cannot be determined until the conditions for issuance are met and the share prices are known upon exercise.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration